Xtrackers Russell 2000 UCITS ETF (ETR:XRS2)

Germany · Delayed Price · Currency is EUR

374.90

-0.45 (-0.12%)

Sep 23, 2026, 12:17 PM CET

Assets	2.40B
Expense Ratio	0.30%
PE Ratio	16.81
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+22.07%

Volume	256
Open	375.50
Previous Close	375.35
Day's Range	374.60 - 375.50
52-Week Low	294.00
52-Week High	396.15
Beta	0.64
Holdings	1965
Inception Date	Mar 6, 2015

About XRS2

Xtrackers Russell 2000 UCITS ETF is an exchange traded fund launched by Concept Fund Solutions Public Limited Company. It is co-managed by Deutsche Asset Management (UK) Limited, Deutsche Asset Management Investment GmbH, and Deutsche International Corporate Services (Ireland) Limited. The fund invests in the public equity markets of the United States. It seeks to invest in the stocks of companies operating across diversified sectors. The fund invests in the stocks of small-cap companies. It seeks to replicate the performance of the Russell 2000 Index, investing in the stocks of companies as per their weightings in the index. The fund was formerly known as Concept Fund Solutions plc - db x-trackers Russell 2000 UCITS ETF (DR). Xtrackers Russell 2000 UCITS ETF was formed on March 6, 2015 and is domiciled in Ireland.

Asset Class Equity

Category Small Cap

Region North America

Stock Exchange Deutsche Börse Xetra

Ticker Symbol XRS2

Provider Xtrackers

Index Tracked Russell 2000

Performance

XRS2 had a total return of 22.07% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.90%.

Top 10 Holdings

3.15% of assets

Name	Symbol	Weight
JFrog Ltd.	FROG	0.35%
Moog Inc.	MOG.A	0.34%
UMB Financial Corporation	UMBF	0.33%
Glaukos Corporation	GKOS	0.33%
Brinker International, Inc.	EAT	0.32%
BrightSpring Health Services, Inc.	BTSG	0.30%
Cytokinetics, Incorporated	CYTK	0.30%
Krystal Biotech, Inc.	KRYS	0.30%
Protagonist Therapeutics, Inc.	PTGX	0.29%
SM Energy Company	SM	0.29%

View More Holdings